Poliovirus receptor (PVR, CD155) and CD112 are ligands expressed on tumor cells that interact with immune receptors, influencing immune suppression and activation (Wu et al., 2024; Murakami and Ganguly, 2024). Here, NECTIN2 is linked to neoplasm.